Charles Schwab’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Charles Schwab’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-543,870	Closed	-$2.07M	–	3401
2020 Q1	$2.07M	Buy	543,870 +8,689	+2%	+$33K	﹤0.01%	2264
2019 Q4	$2.73M	Buy	535,181 +18,009	+3%	+$91.7K	﹤0.01%	2318
2019 Q3	$2.62M	Buy	517,172 +32,744	+7%	+$166K	﹤0.01%	2294
2019 Q2	$2.99M	Buy	484,428 +960	+0.2%	+$5.92K	﹤0.01%	2210
2019 Q1	$2.24M	Buy	483,468 +33,478	+7%	+$155K	﹤0.01%	2330
2018 Q4	$1.89M	Sell	449,990 -5,748	-1%	-$24.1K	﹤0.01%	2351
2018 Q3	$2.86M	Buy	455,738 +64,393	+16%	+$404K	﹤0.01%	2307
2018 Q2	$3.15M	Buy	391,345 +29,724	+8%	+$239K	﹤0.01%	2218
2018 Q1	$2.7M	Buy	361,621 +36,265	+11%	+$271K	﹤0.01%	2216
2017 Q4	$1.94M	Buy	325,356 +2,932	+0.9%	+$17.4K	﹤0.01%	2312
2017 Q3	$2.37M	Buy	322,424 +15,581	+5%	+$115K	﹤0.01%	2226
2017 Q2	$2.08M	Sell	306,843 -35,361	-10%	-$240K	﹤0.01%	2208
2017 Q1	$3.23M	Buy	342,204 +67,271	+24%	+$635K	﹤0.01%	1990
2016 Q4	$2.38M	Sell	274,933 -21,294	-7%	-$184K	﹤0.01%	2109
2016 Q3	$1.88M	Buy	296,227 +79,127	+36%	+$501K	﹤0.01%	2159
2016 Q2	$917K	Buy	217,100 +114,500	+112%	+$484K	﹤0.01%	2377
2016 Q1	$448K	Hold	102,600	–	–	﹤0.01%	2619
2015 Q4	$629K	Sell	102,600 -3,400	-3%	-$20.8K	﹤0.01%	2542
2015 Q3	$607K	Sell	106,000 -173,664	-62%	-$994K	﹤0.01%	2547
2015 Q2	$2.09M	Hold	279,664	–	–	﹤0.01%	2072
2015 Q1	$1.67M	Buy	279,664 +173,664	+164%	+$1.04M	﹤0.01%	2149
2014 Q4	$802K	Hold	106,000	–	–	﹤0.01%	2443
2014 Q3	$551K	Hold	106,000	–	–	﹤0.01%	2551
2014 Q2	$457K	Hold	106,000	–	–	﹤0.01%	2665
2014 Q1	$434K	Buy	106,000 +21,100	+25%	+$86.4K	﹤0.01%	2646
2013 Q4	$453K	Hold	84,900	–	–	﹤0.01%	2626
2013 Q3	$405K	Buy	84,900 +19,600	+30%	+$93.5K	﹤0.01%	2628
2013 Q2	$303K	Buy	+65,300	New	+$303K	﹤0.01%	2725